Overall N=290 N=145 30 (25.1 ,35.6) 3 (0.5, 6.4) - <0.001 CI: confidence interval; HR: hazard ratio; : Intent-to-treat; PFS: progression free survival. Figure 1 Kaplan-Meier Curve for Progression-Free Survival by Independent Assessment for the Overall Population (Treatment-Naïve and Cytokine Pre-Treated Populations) Figure 2 Kaplan-Meier Curve for Progression-Free Survival by Independent Assessment for the Treatment-Naïve Population
- <0.001 Overall N=290 30 (25.1 ,35.6) N=145 3 (0.5, 6.4) CI: confidence interval; HR: hazard ratio; : Intent-to-treat; PFS: progression free survival. Figure 1 Kaplan-Meier Curve for Progression-Free Survival by Independent Assessment for the Overall Population (Treatment-Naïve and Cytokine Pre-Treated Populations) Figure 2 Kaplan-Meier Curve for Progression-Free Survival by Independent Assessment for the Treatment-Naïve Population
auspar-pazopanib-hydrochloride-130225-pi.docx